Valentine's Day is right around the corner but for some, the season of love is all year round. Emily Holmes Hahn, Founder of the matchmaking service LastFirst, joins This Changes Things to discuss building a business based on emotion and passion. You'd think that technology and dating apps would eliminate the need for a matchmaker, but Hahn explains that it actually helps her business model because people are getting frustrated with the lack of solid partners on the apps. She also explains what goes into the name and branding of a business to set it up for success. Plus, Holmes Hahn talks about growing your company organically. She suggests taking the time to see where your customer base is and determine if it makes sense to open an office in that location. For larger companies, she suggests doing some market research before expanding your footprint.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More